- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 2.60 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x AV0: Lauryl Maltose Neopentyl Glycol(Non-covalent)
- 2 x LBN: 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine(Non-covalent)
LBN.3: 15 residues within 4Å:- Chain A: H.210, W.211, G.212, A.215, I.218, L.219, Y.284
- Chain B: F.463, F.467, L.471, A.481, I.482, L.507
- Ligands: AV0.2, AV0.4
13 PLIP interactions:5 interactions with chain B, 8 interactions with chain A- Hydrophobic interactions: B:F.463, B:F.467, B:L.471, B:I.482, B:L.507, A:W.211, A:W.211, A:W.211, A:A.215, A:A.215, A:I.218, A:L.219
- Salt bridges: A:H.210
LBN.10: 15 residues within 4Å:- Chain A: F.463, F.467, L.471, A.481, I.482, L.507
- Chain B: H.210, W.211, G.212, A.215, I.218, L.219, Y.284
- Ligands: AV0.9, AV0.11
13 PLIP interactions:5 interactions with chain A, 8 interactions with chain B- Hydrophobic interactions: A:F.463, A:F.467, A:L.471, A:I.482, A:L.507, B:W.211, B:W.211, B:W.211, B:A.215, B:A.215, B:I.218, B:L.219
- Salt bridges: B:H.210
- 4 x CLR: CHOLESTEROL(Non-covalent)
CLR.5: 10 residues within 4Å:- Chain A: M.262, T.263, W.265, L.266, Y.269, T.290, D.295, M.297, L.419, S.422
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:M.262, A:W.265, A:W.265, A:W.265, A:L.266, A:Y.269, A:Y.269, A:T.290, A:L.419
CLR.6: 12 residues within 4Å:- Chain A: I.183, T.187, T.191, L.322, F.325, S.326, L.329, A.330, F.502, G.505, C.506, F.509
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:I.183, A:T.187, A:T.191, A:L.322, A:L.329, A:L.329, A:A.330, A:F.502, A:F.509
CLR.12: 10 residues within 4Å:- Chain B: M.262, T.263, W.265, L.266, Y.269, T.290, D.295, M.297, L.419, S.422
9 PLIP interactions:9 interactions with chain B- Hydrophobic interactions: B:M.262, B:W.265, B:W.265, B:W.265, B:L.266, B:Y.269, B:Y.269, B:T.290, B:L.419
CLR.13: 12 residues within 4Å:- Chain B: I.183, T.187, T.191, L.322, F.325, S.326, L.329, A.330, F.502, G.505, C.506, F.509
9 PLIP interactions:9 interactions with chain B- Hydrophobic interactions: B:I.183, B:T.187, B:T.191, B:L.322, B:L.329, B:L.329, B:A.330, B:F.502, B:F.509
- 2 x PLM: PALMITIC ACID(Non-covalent)
PLM.7: 10 residues within 4Å:- Chain A: I.96, V.100, R.358, F.361, T.362, I.365, F.546, V.553, I.564, C.565
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:I.96, A:I.96, A:V.100, A:R.358, A:F.361, A:I.365, A:I.365, A:F.546, A:I.564, A:I.564
PLM.14: 10 residues within 4Å:- Chain B: I.96, V.100, R.358, F.361, T.362, I.365, F.546, V.553, I.564, C.565
10 PLIP interactions:10 interactions with chain B- Hydrophobic interactions: B:I.96, B:I.96, B:V.100, B:R.358, B:F.361, B:I.365, B:I.365, B:F.546, B:I.564, B:I.564
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kobayashi, T.A. et al., Dimeric transport mechanism of human vitamin C transporter SVCT1. Nat Commun (2024)
- Release Date
- 2024-06-19
- Peptides
- Solute carrier family 23 member 1: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 2.60 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x AV0: Lauryl Maltose Neopentyl Glycol(Non-covalent)
- 2 x LBN: 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine(Non-covalent)
- 4 x CLR: CHOLESTEROL(Non-covalent)
- 2 x PLM: PALMITIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kobayashi, T.A. et al., Dimeric transport mechanism of human vitamin C transporter SVCT1. Nat Commun (2024)
- Release Date
- 2024-06-19
- Peptides
- Solute carrier family 23 member 1: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A - Membrane
-
We predict this structure to be a membrane protein.